Method for preparing heparin isinglass nanometer grain and heparin encapsulization heart closure device
A nanoparticle and microencapsulation technology, used in medical science, surgery, etc., can solve the problems of decreased activity and fast metabolism of heparin, and achieve the effects of ensuring stability, anticoagulant endothelial cell growth, and shortening the healing process.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0009] Embodiment 1: In this embodiment, heparin gelatin nanoparticles are prepared according to the following steps: (1) chemically degrade heparin into low molecular weight heparin; Dissolve in gelatin solution, then add Tween-20 with 6-7 times the weight of gelatin to make water phase; (3) Put liquid white oil with 95-105 times the weight of gelatin in a water bath at 40-60°C, and stir while stirring Add the water phase dropwise to form a water-in-oil mixed solution, in which the stirring speed is controlled at 7000-11000r / min; (4) The water-in-oil mixed solution is emulsified in a water bath at 40-60°C for 20-30 minutes, and then changed to an ice-water bath 2±0.1h; (5) After the temperature of the water-in-oil mixture returns to room temperature, add formaldehyde with a mass of 8% to 12% of the water-in-oil mixture to solidify for 30-60min, and then add the water-in-oil mixture with a volume of 2 ~3 times of acetone is used for dehydration and deoiling, the acetone dehydr...
specific Embodiment approach 2
[0015] Embodiment 2: The difference between this embodiment and Embodiment 1 is that the gelatin solution in step (2) is made by dissolving gelatin in distilled water by heating and dissolving in a water bath at 60±2°C. Other steps and selected parameters are the same as those in Embodiment 1.
[0016] The concentration of the gelatin solution in this embodiment has no effect on the spheroidization and preparation of the heparin-gelatin nanoparticles.
specific Embodiment approach 3
[0017] Embodiment 3: The difference between this embodiment and Embodiment 1 is that in step (2), the low molecular weight heparin is dissolved in the gelatin solution at a mass ratio of low molecular weight heparin to gelatin of 0.8-3:10. Other steps and selected parameters are the same as those in Embodiment 1.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Concentration | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
